Irodalom:
1. Asmussen L, Pachler J et al: Colorectal carcinoma with dome-like phenotype: an under-recognised subset
of colorectal carcinoma? J Clin Pathol. (2008) 61:482-486.
2. Baretton GB, Aust DE: Intraepithelial neoplasia/dysplasia – Histopathology in ulcerative colitis.
Pathologe. (2008) Nov;29 Suppl 2:280-5.
3. Cho YB, Yun SH et al: Carcinoma obstruction of the left colon and long-term prognosis.
Hepatogastroenterology. (2008) 55:1288-1292.
4. Davies M, Arumugam PJ et al: The clinical significance of lymph node micrometastasis in stage I and
stage II colorectal cancer. Clin Transl Oncol. (2008) 10:175-179.
5. Faerden AE, Sjo O et al: Sentinel lymph node mapping does not improve staging of lymph node metastases
Gastro 2009.qxd 5/9/2009 1:41 PM Page 239
in colonic cancer. Dis Colon Rectum. (2008) 51:891-896.
6. Fujii S, Katsumata D et al: Limits of diagnosis and molecular markers for early detection of ulcerative
colitis-associated colorectal neoplasia. Digestion. (2008) 77 Suppl 1:2-12.
7. Gelos M, Gelhaus J et al: Factors influencing lymph node harvest in colorectal surgery. Int J Colorectal
Dis. (2008) 23:53-59.
8. Hohenberger W, Matzel KE et al: Standardised Surgery for Colonic Cancer: Complete mesocolic excision
(CME) and central ligation – Technical notes and outcome. Colorectal Dis. (2008) Nov 7. [Epub ahead
of print]
9. Jiang Y, Casey G et al: Development of a clinically feasible molecular assay to predict recurrence of
stage II colon cancer. J Mol Diagn. (2008) 10:346-354.
10. Jiao YF, Nakamura S et al: Serrated adenoma of the colorectum undergoes a proliferation versus
differentiation process: new conceptual interpretation of morphogenesis. (2008) 74:127-34.
11. Jimi S, Hotokezaka M et al: Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Hepatogastroenterology. (2008) 55:926-929.
12. Kanazawa H, Mitomi H et al: Tumour budding at invasive margins and outcome in colorectal cancer.
Colorectal Dis. (2008) 10:41-47.
13. Kil Lee, Il Kim T et al: 1: Comparison of the clinicopathologic features between flat and polypoid adenoma.
Scand J Gastroenterol. (2008) 43:1116-21.
14. Koga Y, Yao T et al: Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated
by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma
sequence. Histopathology. (2008) 52:569-77.
15. Kukitsu T, Takayama T et al: Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in
patients with ulcerative colitis. Clin Cancer Res. (2008) 14:48-54.
16. Nakamura T, Mitomi H et al: Tumor budding as an index to identify high-risk patients with stage II colon
cancer. Dis Colon Rectum. (2008) 51:568-572.
17. Ohtsuki K, Koyama F et al: Prognostic value of immunohistochemical analysis of tumor budding in
colorectal carcinoma. Anticancer Res. (2008) 28:1831-1836.
18. Park DH, Kim HS et al: Clinicopathologic characteristics and malignant potential of colorectal flat
neoplasia compared with that of polypoid neoplasia. Dis Colon Rectum. (2008) 51:43-9.
19. Polydorides AD, Mukherjee B et al: Adenoma-infiltrating lymphocytes (AILs) are a potential marker of
hereditary nonpolyposis colorectal cancer. Oncology. Am J Surg Pathol. (2008) 32:1661-1666.
20. Quah HM, Chou JF et al: Identification of patients with high-risk stage II colon cancer for adjuvant
therapy. Dis Colon Rectum. (2008) 51:503-507.
21. Rasheed S, Bowley DM et al: Can depth of tumour invasion predict lymph node positivity in patients
undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
Colorectal Dis. (2008) 10:231-238.
22. Rubio CA.: Arrest of cell proliferation in budding tumor cells ahead of the invading edge of colonic
carcinomas. A preliminary report. Anticancer Res. (2008) 28:2417-2420.
23. Schlemper RJ, Riddel RH et al: The Vienna Classification of gastrointestinal epithelial neoplasia. Gut
(2000) 47: 251-255.
24. Scott N, Jamali A et al: Retroperitoneal margin involvement by adenocarcinoma of the caecum and
ascending colon: what does it mean? Colorectal Dis. (2008) 10:289-293.
240 Gastro Update 2009
Gastro 2009.qxd 5/9/2009 1:41 PM Page 240
A vastagbél 241
25. Sträter J, Wiesmüller C et al: Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in
Barrett’s and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial
neoplasia. Histopathology. (2008) 52:399-402.
26. Tsai HL, Yeh YS et al: Predicting factors of postoperative relapse in T(2-4)N (0)M (0) colorectal cancer
patients via harvesting a minimum of 12 lymph nodes. Int J Colorectal Dis. (2008) Oct 14. [Epub ahead
of print]
27. Uen YH, Lu CY et al: Persistent presence of postoperative circulating tumor cells is a poor prognostic
factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol. (2008)
15:2120-2128.
28. Wang LM, Kevans D et al: Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0
Colorectal Cancer. Am J Surg Pathol. 2008 Oct 28. [Epub ahead of print]
29. West NP, Morris EJ et al: Pathology grading of colon cancer surgical resection and its association with
survival: a retrospective observational study. Lancet Oncol. (2008) 9:857-865.
30. Zlobec I, Baker K et al: Node-negative colorectal cancer at high risk of distant metastasis identified by
combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Clin Cancer Res. (2008)14:143-8.
31. Zlobec I, Terracciano LM et al: Local recurrence in mismatch repair-proficient colon cancer predicted by
an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes. Clin Cancer Res. (2008)
14:3792-3797.
